Emerging Leaders 2025

 

Endocrine-Related Cancer Emerging Leaders special collection banner

 

This collection highlights the breadth and quality of research being undertaken in the endocrine cancer field by truly exceptional early-career researchers. Here at Endocrine-Related Cancer, we are committed to supporting scientists at the early stage of their careers, and wish to recognise and celebrate their diverse knowledge and talents.

‘Emerging Leaders 2025’ is an invite-only collection, including both reviews and original research articles. Researchers are nominated by the editorial board and associated societies. The following eligibility criteria must be met:

  • Scientists: <10 years (or working time equivalent) post PhD with at least three publications as first, co-first or as senior author
  • Physicians: <12 years (or working time equivalent) from completion of MD or MD, PhD with at least three publications as first, co-first or as senior author

All articles will go through a rigorous peer review process; an invitation is not a guarantee of acceptance.

 

One winner will be chosen by Matthew Ringel, Editor-in-Chief, and Márta Korbonits, Deputy Editor, and will receive a prize of £250. All researchers whose articles are accepted will have their profile and work shared on our social media channels.

If you know an exceptional early-career researcher, and would like to nominate them to receive an invitation to contribute to this collection, please contact us as erc@bioscientifica.com with their CV and proposed article type and topic for consideration

 

Articles published within the special collection:

 

Management of advanced high grade gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): comprehensive review of the current literature
A Mohamed, M Trybula, S L Asa, T R Halfdanarson, and M B Sonbol

Gut microbial and functional alterations lead to metagenomic signatures for midgut neuroendocrine tumor patients and for carcinoid syndrome
Merijn C F Mulders, Peter M Van Koetsveld, Richard A Feelders, Leo J Hofland, Wouter W de Herder, Robert Kraaij, and Johannes Hofland

Evaluating the prognostic potential of circulating cell-free DNA in advanced thyroid cancer
Ayanthi Wijewardene, Roderick J Clifton-Bligh, Bin Wang, Catherine Luxford, Bruce G Robinson, Martyn Bullock, and Matti Gild

Bone metastasis in endocrine-related cancer: unravelling invasion and destruction
Huong Q Duong, Georgia Kafer, and Michelle Maugham-Macan

The complex landscape of luminal breast cancer
Catrin Lutz, Hendrik A Messal, Damir Vareslija, and Stefan Prekovic

Chemokines with CXC motif and their receptors in neuroendocrine neoplasms
Karolina Merecz, Pawel Hikisz, Aleksandra Tarasiuk-Zawadzka, Jakub Fichna, and Damian Jacenik

Clinicopathological characteristics associated with the prognosis of recurrent gonadotroph tumors
Chrysi Kaparounaki, Alexandre Vasiljevic, Emmanuel Jouanneau, Camille Sergeant, Gérald Raverot, and Mirela-Diana Ilie

CCL2 expression predicts clinical outcomes and regulates E-cadherin and angiogenesis in pituitary tumours
Ana Luísa Silva, Sayka Barry, Mariana Lopes-Pinto, Rita Joaquim, Catarina Miranda, Fábio Reis, Micaella Miranda, Paulo Matos, Oniz Suleyman, Tiago Oliveira, Dolores López-Presa, Gonçalo Borrecho, Francisco Tortosa, Claúdia C Faria, Márta Korbonits, and Pedro Marques

From bench to bedside in the sella: translational developments in pituitary tumour genetics
Sunita M C De Sousa

Management of high-grade neuroendocrine neoplasms: impact of functional imaging
O Islam, K Sarti, L Verbruggen, V Vandersmissen, K Vanden Bulcke, L Annys, C Verslype, J L Van Laethem, H Rezaei Kalantari, J Janssens, A Hendlisz, P J Cuyle, G Demolin, J Decaestecker, K Geboes, J C Coche, J Van Ongeval, W Lybaert, M Peeters, I Borbath, and T Vandamme

FT3 and FT3/FT4 ratio are decreased and not compensated by levothyroxine treatment in TKI-treated thyroid cancer patients
Tommaso Porcelli, Cristina Luongo, Anna Cerbone, Carmine Di Luccio, Maria Angela De Stefano, and Domenico Salvatore

 

Collection Editors

 

Photograph of Matthew Ringel

Dr Matthew Ringel, Editor-in-Chief
Ralph W Kurtz Professor of Medicine,
and Director of the Division of Endocrinology and Metabolism,
The Ohio State University,
OH, USA

 

Photograph of Márta Korbonits

Professor Márta Korbonits, Deputy Editor
Professor of Endocrinology and Metabolism,
William Harvey Research Institute,
Barts and the London School of Medicine,
Queen Mary University of London, UK